Lucio's Phenomenon: Response to Alternative Treatment with Multibacilar Polychemotherapy

  • Camila Araujo Dantas Residente em Dermatologia/Resident of Dermatology, Faculdade Estadual de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, Brasil
  • Caroline Medeiros Prohmann Residente em Dermatologia/Resident of Dermatology, Faculdade Estadual de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, Brasil
  • Lorena Barcelos e Silva Residente em Dermatologia/Resident of Dermatology, Faculdade Estadual de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, Brasil
  • Rafael Figueiredo Gatti Residente em Dermatologia/Resident of Dermatology, Faculdade Estadual de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, Brasil
  • Thalita Marçal Machado Dermatologista/Dermatologist pela Faculdade Estadual de Medicina de São José do Rio Preto (FAMERP), membro da Sociedade Brasileira de Dermatologia (SBD)
  • Rosa Maria Cordeiro Soubhia Professora e chefe do Ambulatório de Hanseníase do serviço de Dermatologia do Hospital de Base de São José do Rio Preto – FAMERP, Brasil
  • João Roberto Antonio Dermatologista/Dermatologist, Membro da SBD e Chefe do Ambulatório de Dermatologia e Professor Emérito da Faculdade Estadual de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, Brasil
DOI: https://doi.org/10.29021/spdv.76.2.804
Keywords: Drug Therapy, Combination, Leprosy, Lepromatous, Mycobacterium leprae

Abstract

Leprosy is an infectious disease of chronic evolution caused by Mycobacterium leprae. Its chronic course can be interrupted by acute or subacute reactional episodes. Lucius phenomenon is a vasculitic immune reaction that occurs in patients with lepromatous leprosy. It appears with purpuric macules that progress to ascending necrosis and ulceration and heal with an atrophic scar. The authors describe the case of a 73-year-old male patient with ulceronecrotic lesions in the lower limbs and tendinous calcaneal exposure. Clinical-laboratory data and dermatological examination confirmed the diagnosis of lepromatous leprosy with vasculitis of the Lucius-like type. It progressed with a good response to the alternative treatment with multibacillary multidrug therapy.

Downloads

Download data is not yet available.

Author Biography

Camila Araujo Dantas, Residente em Dermatologia/Resident of Dermatology, Faculdade Estadual de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, Brasil
Residente em Dermatologia na Faculdade Estadual de Medicina de São José do Rio Preto - FAMERP

References

Karg E, Korom I, Varga E, Ban G, Turi S. Congenital 1. Belda Júnior W, Di Chiacchio N, Criado PR. Tratado de Dermatologia. 2ª ed. São Paulo: Atheneu; 2014.

World Health Organization. Global Leprosy Strategy: Accelerating towards a leprosy-free world. Geneve: WHO; 2016.

Souza CS. Hanseníase: formas clínicas e diagnóstico diferencial. Med Ribeirão Preto. 1997;30:325-34.

Vera-Cabrera L, Escalante-Fuentes WG, Gomez-Flores M, Ocampo-Candiani J, Busso P, Singh P, et al. Case of diffuse lepromatous leprosy associated with "Mycobacterium

lepromatosis". J Clin Microbiol. 201;49:4366-8.

Azulay-Abulafia L. Revendo a hanseníase de Lucio e o fenómeno de Lucio. Med Cutan Iber Lat Am 2005;33:125-33.

Rivitti, Evandro A. Manual de dermatologia clínica de Sampaio e Rivitti. São Paulo: Artes Médicas; 2014.

Helmer KA, Fleischfresser I, Kucharski-Esmanhoto LD, Neto JF, Santamaria JR. The Lucio's phenomenon (necrotizing erythema) in pregnancy. An Bras Dermatol. 2004;79:205-10.

Antonio JR, Cipullo JP, Soubhia RC, D´Ávila SC, Neto DS, Pereira AS. Lucio's phenomenon. RBM. 2003;62:103-6.

Ribeiro SLE, Erilane, Pereira HLA, Sales LS. Vasculite na hanseníase mimetizando doenças reumáticas. Rev Bras Reumatol. 2007; 47:140-4.

Bernadat JP, Faucher JF, Huerre M. Diffuse lepromatous leprosy disclosed by cutaneous vasculitis: the Lucio phenomenon. Ann Dermatol Venereol. 1996;123:21-3.

Report of the International Leprosy Association, Technical Forum Paris, France 22-28 February 2002. Int J Leprosy. 2002;70:21-2.

Azulay-Abulafia, L., and L. Spinelli. Revendo a hanseníase de Lúcio e o Fenômeno de Lúcio. Med Cutan Iber Lat Am. 2005;33: 125-33.

Peixoto AB, Portela OS, Leal FR, Brotas AM, Rodrigues NS. Lucio's Phenomenon. Case study of an exceptional response to treatment exclusively with multibacillary multidrug

therapy. An Bras Dermatol. 2013;88:93-6.

Soares R, Silva RC, Ceribelli AC, Ura . Lucio’s phenomenon - Case report. Hansenologia Internationalis. 2009; 34:47-51.

Monteiro R, Tiezzi MG, Abreu MA, Oliveira CC, Roncada EV, Ortigosa LC. Lucio's phenomenon: another case reported in Brazil. An Bras Dermatol. 2012; 87:296-300.

Pereira AC Jr. Hanseníase de Lúcio. An Bras Dermatol. 1993;68:33-40.

Ferreira LM, Medeiros AP, Gasparelo LG. Fenómeno de Lúcio. Rev Soc Port Dermatol Venereol. 2015;73: 485-8.

Gillis TP, Scollard DM, Lockwood DN. What is the evidence that the putative Mycobacterium lepromatosis species causes diffuse lepromatous leprosy? Lepr Rev.

;82:205-9.

Published
2018-05-29
How to Cite
Araujo Dantas, C., Medeiros Prohmann, C., Barcelos e Silva, L., Figueiredo Gatti, R., Marçal Machado, T., Cordeiro Soubhia, R. M., & Antonio, J. R. (2018). Lucio’s Phenomenon: Response to Alternative Treatment with Multibacilar Polychemotherapy. Journal of the Portuguese Society of Dermatology and Venereology, 76(2), 185-188. https://doi.org/10.29021/spdv.76.2.804
Issue
Vol 76 No 2 (2018): April - June
Section
Case Reports

All articles in this journal are Open Access under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).

Most read articles by the same author(s)